tirzepatide semaglutide peptide or small molecule Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction | Cardiovascular Diabetology Can Small Molecules Compete With

Study the signals of amplified dual-incretin coordination

Studies by The New England Journal

Clinical studies show semaglutide users lose 1022% of baseline body weight, though individual results vary significantly

Explore how GLP-1 medications like Ozempic and Wegovy might reduce substance cravings and help treat addiction.

Discover expert guidance on alcohol consumption with GLP-1 medications like Wegovy, Saxenda, and Mounjaro, including safety considerations, side effects, and UK clinical recommendations for optimal treatment outcomes.

The other major concern here is the lack of oversight from these telehealth platforms selling compounded GLP-1s